1 / 11

Beyond Treatment Demand Towards Outcomes Michael Donmall & Andrew Jones

National Drug Evidence Centre. Beyond Treatment Demand Towards Outcomes Michael Donmall & Andrew Jones National Drug Evidence Centre (NDEC) University of Manchester www.manchester.ac.uk/ndec. National Drug Evidence Centre. Beyond Treatment Demand Towards Outcomes.

lilka
Download Presentation

Beyond Treatment Demand Towards Outcomes Michael Donmall & Andrew Jones

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. National Drug Evidence Centre Beyond Treatment Demand Towards Outcomes Michael Donmall & Andrew Jones National Drug Evidence Centre (NDEC) University of Manchester www.manchester.ac.uk/ndec

  2. National Drug Evidence Centre Beyond Treatment Demand Towards Outcomes Treatment Demand Indicator (TDI) 20 core items of data Issues of implementation Definition Quality & coverage Analytic methods & pitfalls Completion of tables! • The extent and nature of presenting • problem drug misuse

  3. National Drug Evidence Centre An epidemiological indicator A monitoring tool An epidemiological monitoring tool Beyond Treatment Demand Towards Outcomes What can TDI achieve? nos & profiles use of services minimum need assist in planning risk assessment area differences identify trends, sub-groups specific drugs with usual caveats! combine with other indicators capture/ re-cap pop estimates prevalence of problem drug use

  4. National Drug Evidence Centre

  5. National Drug Evidence Centre Beyond Treatment DemandTowards Outcomes Feedback Capture Feedback Loop Analysis

  6. National Drug Evidence Centre Epidemiological Tool Performance Management Tool Outcomes Tool Beyond Treatment DemandTowards Outcomes profiles patterns trends prevalence estimates throughput waiting times engagement retention in treatment needs assesssment unit costs drug use mental health physical health psychological well being crime social “success”

  7. National Drug Evidence Centre Beyond Treatment DemandTowards Outcomes UK - England • Addicts Index 1968-1997, Home Office • Drug Misuse Database (DMD) 1990-2000, Dept of Health • Review  National Drug Treatment Monitoring System (NDTMS) 2000-01 • NDTMS – NTA 2001 – 2004, 2004 - present • NTORS 1995, DTORS 2005-2007

  8. National Drug Evidence Centre DTORS Drug Treatment Outcomes Research Study (DTORS) Home Office, NDEC/ NatCen Outcomes Study 100 DATs, 3,000 baseline treatment seekers 3 & 12 month follow-up Domains Social circumstances Drug use Offending Risk taking Physical health Mental health Motivation Treatment history Pathways Qualitative study In-depth interviews Treatment decisions/ experiences Service users Service providers Cost Benefits Analysis Costs of treatment Value of outcomes Net benefit of treatment

  9. National Drug Evidence Centre Workshop To what extent can outcome measurement be achieved through monitoring systems? www.manchester.ac.uk/ndec www.ndtms.net www.dtors.org.uk

  10. National Drug Evidence Centre Beyond Treatment Demand Towards Outcomes Key Epidemiological Indicators provide a broad, comparative description of the state of, and trends in, drug use in Europe Treatment Demand Indicator Information on problem drug users and their patterns of use (injecting, multiple drug use, etc.) used to: • identify patterns in the use of services; • assess the need for resources; and • plan and evaluate services for drug users • an indirect indicator of trends in problem drug use • a rich basis for assessment of the prevalence of problematic drug use

More Related